Determination of Δ9-tetrahydrocannabinol, 11-nor-carboxy-Δ9-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake
Forensic Toxicology · 2024
DOI: 10.1007/s11419-024-00686-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Forensic Toxicology, 2024. Verfasst von Ioannis Papoutsis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. ipapoutsis@med.uoa.gr. Hauptthemen laut MEDLINE: Cannabidiol, Gas Chromatography-Mass Spectrometry, Dronabinol, Limit of Detection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Athens.
Abstract (Originalsprache)
Purpose
Cannabidiol (CBD) products are widely used for pain relief, sleep improvement, management of seizures etc. Although the concentrations of Δ 9 -tetrahydrocannabinol (Δ 9 -THC) in these products are low (≤0.3% w/w), it is important to investigate if its presence and/or that of its metabolite 11-nor-carboxy-Δ 9 -THC, is traceable in plasma and urine samples of individuals who take CBD oil products.
Methods
A sensitive GC/MS method for the determination of Δ 9 -THC, 11-nor-carboxy-Δ 9 -THC and CBD in plasma and urine samples was developed and validated. The sample preparation procedure included protein precipitation for plasma samples and hydrolysis for urine samples, solid-phase extraction and finally derivatization with N ,O-bis(trimethylsilyl)trifluoroacetamide) with 1% trimethylchlorosilane.
Results
For all analytes, the LOD and LOQ were 0.06 and 0.20 ng/mL, respectively. The calibration curves were linear ( R 2 ≥ 0.992), and absolute recoveries were ≥91.7%. Accuracy and precision were within the accepted range. From the analysis of biologic samples of 10 human participants who were taking CBD oil, it was realized that Δ 9 -THC was not detected in urine, while 11-nor-carboxy-Δ 9 -THC (0.69–23.06 ng/mL) and CBD (0.29–96.78 ng/mL) were found in all urine samples. Regarding plasma samples, Δ 9 -THC (0.21–0.62 ng/mL) was detected in 10, 11-nor-carboxy-Δ 9 -THC (0.20–2.44 ng/mL) in 35, while CBD (0.20–1.58 ng/mL) in 25 out of 38 samples, respectively.
Conclusion
The results showed that Δ 9 -THC is likely to be found in plasma although at low concentrations. In addition, the detection of 11-nor-carboxy-Δ 9 -THC in both urine and plasma samples raises questions and concerns for the proper interpretation of toxicological results, especially considering Greece’s zero tolerance law applied in DUID and workplace cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. ipapoutsis@med.uoa.gr.
- Department of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Division of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Ioannis Papoutsis
Förderung
- University of Athens
Zitieren
APA
Papoutsis, I., Hatzidouka, V., Ntoupa, S. P., Angelis, A., Dona, A., Sakelliadis, E., & Spiliopoulou, C. (2024). Determination of Δ9-tetrahydrocannabinol, 11-nor-carboxy-Δ9-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake. Forensic Toxicology. https://doi.org/10.1007/s11419-024-00686-0
Vancouver
Papoutsis I, Hatzidouka V, Ntoupa SP, Angelis A, Dona A, Sakelliadis E, et al. Determination of Δ9-tetrahydrocannabinol, 11-nor-carboxy-Δ9-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake. Forensic Toxicology. 2024. doi:10.1007/s11419-024-00686-0
BibTeX
@article{Papoutsis2024,
author = {Papoutsis, Ioannis and Hatzidouka, Vasiliki and Ntoupa, Stamatina-Panagoula and Angelis, Apostolis and Dona, Artemisia and Sakelliadis, Emmanouil and Spiliopoulou, Chara},
title = {Determination of Δ9-tetrahydrocannabinol, 11-nor-carboxy-Δ9-tetrahydrocannabinol and cannabidiol in human plasma and urine after a commercial cannabidiol oil product intake},
journal = {Forensic Toxicology},
year = {2024},
doi = {10.1007/s11419-024-00686-0}
}
EUVIMED